
At the 6th World Congress of Cutaneous Lymphoma, a group of world-leading CTCL expert consider what the field will abandon in the next decade.

Stefan K. Barta, MD, MS, is the director of the T-cell lymphoma program, Executive Officer of the Consortium for Advancing Management and Pervention of Cancer in People with HIV, and an Associate Professor of Medicine at the Hospital of the University of Pennsylvania.

At the 6th World Congress of Cutaneous Lymphoma, a group of world-leading CTCL expert consider what the field will abandon in the next decade.

Stefan K. Barta, MD, MS, discusses how to distinguish MAR from mycosis fungoides lesions in cutaneous T-cell lymphoma.